Literature DB >> 22924939

Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension.

Jing Li1, Jie Song, Min-Hui Jiang, Jin-Guo Zheng, Shu-Ping Gao, Jian-Hua Zhu, Min Pan.   

Abstract

There is an accumulating body of evidence indicating a strong association between inflammation and the pathogenesis of atrial fibrillation (AF). Interleukin-6 (IL-6) is a pleiotropic cytokine, functions as a mediator of inflammatory response, and has both proinflammatory and anti-inflammatory properties. The aim of the present study was to investigate the association of the -634C/G polymorphism of the IL-6 gene with AF in elderly Han Chinese patients with essential hypertension (EH). A total of 169 elderly patients with EH were eligible for this study. Patients with AF (n=75) were allocated to the AF group, and 94 subjects without AF to the control group. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used to assess the genotype frequencies. The distribution of the IL-6 -634C/G genotypes (CC, CG, and GG) was 67.02%, 30.85%, and 2.13% in the controls, and 50.67%, 40.00%, and 9.33% in AF subjects, respectively (P=0.0312). The frequency of the G allele in the AF group was significantly higher than that in the control group (29.33% vs. 17.55%, P=0.0103). Compared with the CC and CG genotypes, the GG homozygote had a 4.7353-fold increased risk of AF [95% confidence interval (CI)=0.9537-23.5116, P=0.0382]. These findings suggest that the IL-6 -634C/G polymorphism is associated with AF, and the G allele has increased risk of AF in elderly Han Chinese patients with EH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924939      PMCID: PMC3493041          DOI: 10.1089/jir.2012.0033

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  58 in total

1.  Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Authors:  C F Terry; V Loukaci; F R Green
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

2.  The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

Authors:  S E Humphries; L A Luong; M S Ogg; E Hawe; G J Miller
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

3.  C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation.

Authors:  J Dernellis; M Panaretou
Journal:  Acta Cardiol       Date:  2001-12       Impact factor: 1.718

4.  Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.

Authors:  Nobuto Shibata; Tohru Ohnuma; Tadashi Takahashi; Hajime Baba; Takuya Ishizuka; Mieko Ohtsuka; Akira Ueki; Masatsugu Nagao; Heii Arai
Journal:  Am J Med Genet       Date:  2002-05-08

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes.

Authors:  A Kitamura; G Hasegawa; H Obayashi; K Kamiuchi; M Ishii; M Yano; T Tanaka; M Yamaguchi; H Shigeta; M Ogata; N Nakamura; T Yoshikawa
Journal:  Diabet Med       Date:  2002-12       Impact factor: 4.359

7.  Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population.

Authors:  I Pantsulaia; Ia Pantsulaia; Svetlana Trofimov; Eugene Kobyliansky; Gregory Livshits
Journal:  Cytokine       Date:  2002-08-07       Impact factor: 3.861

8.  Atrial fibrillation in hypertension: predictors and outcome.

Authors:  Paolo Verdecchia; GianPaolo Reboldi; Roberto Gattobigio; Maurizio Bentivoglio; Claudia Borgioni; Fabio Angeli; Erberto Carluccio; Maria Grazia Sardone; Carlo Porcellati
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

View more
  12 in total

1.  In-hospital clinical outcomes of elderly patients (≥60 years) undergoing primary percutaneous coronary intervention.

Authors:  Ya-Min Su; Xing-Xing Cai; Hai-Hua Geng; Hong-Zhuan Sheng; Meng-Kan Fan; Min Pan
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Association of Interleukin-10 promotor polymorphisms with atrial fibrillation in Han Chinese.

Authors:  Dong-Dong Zheng; Shun-Nian Ji; Chu Chen; Xin-Tao Deng; Ya-Min Su; Hai-Yan Pan; Xing-Xing Cai; Xiao-Fei Li; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  A functional single-nucleotide polymorphism in interleukin-6 promoter is associated with p wave dispersion in hypertensive subjects with atrial fibrillation.

Authors:  Hai-Hua Geng; Rui Li; Ya-Min Su; Hai-Yan Pan; Min Pan; Xiao-Ping Ji
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Authors:  Gui-Liang Shi; Xing-Xing Cai; Ya-Min Su; Chu Chen; Xin-Tao Deng; Hai-Yan Pan; Meng-Kan Fan; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  Interleukin-6 genotypes and serum levels in Chinese Hui population.

Authors:  Shu-Ping Gao; Shu Liang; Min Pan; Rong-Liang Sun; Chu Chen; Hong Luan; Min-Hui Jiang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

6.  Interleukin-6 promotor polymorphisms and coronary vasospastic angina in Han Chinese.

Authors:  Ying Wang; Gang Li; Ya-Min Su; Hai-Yan Pan; Hai-Hua Geng; Meng-Kan Fan; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

7.  IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.

Authors:  Gilberto Vargas-Alarcón; Carlos Posadas-Romero; Teresa Villarreal-Molina; Edith Alvarez-León; Javier Angeles-Martinez; Rosalinda Posadas-Sanchez; Irma Monroy-Muñoz; Sergio Luna-Fuentes; Carmen González-Salazar; Julian Ramirez-Bello; Guillermo Cardoso-Saldaña; Aida Medina-Urrutia; Eric Kimura-Hayama
Journal:  J Interferon Cytokine Res       Date:  2014-02-19       Impact factor: 2.607

Review 8.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

9.  Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension.

Authors:  Min-Hui Jiang; Ya-Min Su; Jian-Zhong Tang; Yan-Bo Shen; Xin-Tao Deng; Ding-Shan Yuan; Jie Wu; Min Pan; Zhong-Wei Huang
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365

10.  Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes.

Authors:  Zhaowen Wang; Shaohan Wu; Jianhua Liao; Lin Zhong; Tonghai Xing; Junwei Fan; Zhihai Peng
Journal:  Int J Mol Med       Date:  2016-05-18       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.